Indaptus Therapeutics INDP
NASDAQ INDP
$2.12 -0.18 (-7.83%)
At close: Oct 1, 2026 · 4:00 PM EDT

Indaptus Therapeutics (INDP) Non Operating Interest Expenses (2020 - 2021)

Updated

Indaptus Therapeutics (INDP) reported Non Operating Interest Expenses of -$35,000 for Q2 2021, compared with $4,000 a year earlier.

Analysis

Indaptus Therapeutics (INDP) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

Over the twelve months ended Jun 30, 2021, Indaptus Therapeutics' Non Operating Interest Expenses came in at -$132,000.

  • The Q2 2021 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Indaptus Therapeutics 147.46 Mn 120.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -35,000.00
Mar 31, 2021 -31,000.00
Jun 30, 2020 4,000.00
Mar 31, 2020 -70,000.00
API Access

Indaptus Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INDP&period=max&api_key=YOUR_API_KEY